Profound Medical Corp. (PROF)

8.03 +0.23 (+2.95%) At close: 04:00PM EDT

Profound Medical Corp.

2400 Skymark Avenue
Unit 6
Mississauga, ON L4W 5K5
Canada
647 476 1350
https://www.profoundmedical.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 131

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Arun Swarup Menawat MBA, Ph.D.	Chairman of the Board & CEO	435.87k	N/A	1955
Mr. Rashed Dewan	Chief Financial Officer	215.18k	N/A	1968
Dr. Mathieu Burtnyk	Chief Operating Officer	215.18k	N/A	1982
Mr. Hartmut Warnken	Chief Commercial Officer of Outside US	226.17k	N/A	1973
Mr. Abbey Goodman	Chief Commercial Officer of US	374.35k	N/A	1983
Mr. Stephen Kilmer	Investor Relations	N/A	N/A	N/A
Mr. Jacques F. Cornet	Senior VP & Product Leader Sonalleve	N/A	N/A	1956
Mr. Matthew Sobczyk C.A., CPA	Assistant Corporate Controller	N/A	N/A	N/A
Mr. Levant Tinaz	Software Developer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Corporate governance

Profound Medical Corp.’s ISS governance QualityScore as of 1 April 2024 is 6. The pillar scores are Audit: 8; Board: 5; Shareholder rights: 2; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.